ATC code C02
ATC code C02 Antihypertensives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C02 is part of the anatomical group C Cardiovascular system. Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC02. National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| ATC code C: Cardiovascular system |
|---|
|
| Other ATC codes |
ATC code C02 Antihypertensives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C02 is part of the anatomical group C Cardiovascular system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC02.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C02A Antiadrenergic agents, centrally acting
[edit]C02AA Rauvolfia alkaloids
[edit]- C02AA01 Rescinnamine
- C02AA02 Reserpine
- C02AA03 Combinations of rauwolfia alkaloids
- C02AA04 Rauwolfia alkaloids, whole root
- C02AA05 Deserpidine
- C02AA06 Methoserpidine
- C02AA07 Bietaserpine
- C02AA52 Reserpine, combinations
- C02AA53 Combinations of rauwolfia alkaloids, combinations
- C02AA57 Bietaserpine, combinations
C02AB Methyldopa
[edit]- C02AB01 Methyldopa (levorotatory)
- C02AB02 Methyldopa (racemic)
C02AC Imidazoline receptor agonists
[edit]- C02AC01 Clonidine
- C02AC02 Guanfacine
- C02AC04 Tolonidine
- C02AC05 Moxonidine
- C02AC06 Rilmenidine
C02B Antiadrenergic agents, ganglion-blocking
[edit]C02BA Sulfonium derivatives
[edit]- C02BA01 Trimetaphan
C02BB Secondary and tertiary amines
[edit]- C02BB01 Mecamylamine
C02BC Bisquaternary ammonium compounds
[edit]C02C Antiadrenergic agents, peripherally acting
[edit]C02CA Alpha-adrenoreceptor antagonists
[edit]- C02CA01 Prazosin
- C02CA02 Indoramin
- C02CA03 Trimazosin
- C02CA04 Doxazosin
- C02CA06 Urapidil
C02CC Guanidine derivatives
[edit]- C02CC01 Betanidine
- C02CC02 Guanethidine
- C02CC03 Guanoxan
- C02CC04 Debrisoquine
- C02CC05 Guanoclor
- C02CC06 Guanazodine
- C02CC07 Guanoxabenz
C02D Arteriolar smooth muscle, agents acting on
[edit]C02DA Thiazide derivatives
[edit]- C02DA01 Diazoxide
C02DB Hydrazinophthalazine derivatives
[edit]- C02DB01 Dihydralazine
- C02DB02 Hydralazine
- C02DB03 Endralazine
- C02DB04 Cadralazine
C02DC Pyrimidine derivatives
[edit]- C02DC01 Minoxidil
C02DD Nitroferricyanide derivatives
[edit]- C02DD01 Nitroprusside
C02DG Guanidine derivatives
[edit]- C02DG01 Pinacidil
C02K Other antihypertensives
[edit]C02KA Alkaloids, excluding rauwolfia
[edit]- C02KA01 Veratrum
C02KB Tyrosine hydroxylase inhibitors
[edit]- C02KB01 Metirosine
C02KC MAO inhibitors
[edit]- C02KC01 Pargyline
C02KD Serotonin antagonists
[edit]- C02KD01 Ketanserin
C02KN Other antihypertensives
[edit]- C02KN01 Aprocitentan
- C02KN02 Baxdrostat
C02KX Antihypertensives for pulmonary arterial hypertension
[edit]- C02KX01 Bosentan
- C02KX02 Ambrisentan
- C02KX03 Sitaxentan
- C02KX04 Macitentan
- C02KX05 Riociguat
- C02KX06 Sotatercept
- C02KX52 Ambrisentan and tadalafil
- C02KX54 Macitentan and tadalafil
C02L Antihypertensives and diuretics in combination
[edit]C02LA Rauwolfia alkaloids and diuretics in combination
[edit]- C02LA01 Reserpine and diuretics
- C02LA02 Rescinnamine and diuretics
- C02LA03 Deserpidine and diuretics
- C02LA04 Methoserpidine and diuretics
- C02LA07 Bietaserpine and diuretics
- C02LA08 Rauwolfia alkaloids, whole root and diuretics
- C02LA09 Syrosingopine and diuretics
- C02LA50 Combinations of rauwolfia alkaloids and diuretics including other combinations
- C02LA51 Reserpine and diuretics, combinations with other drugs
- C02LA52 Rescinnamine and diuretics, combinations with other drugs
- C02LA71 Reserpine and diuretics, combinations with psycholeptics
C02LB Methyldopa and diuretics in combination
[edit]- C02LB01 Methyldopa (levorotatory) and diuretics
C02LC Imidazoline receptor agonists in combination with diuretics
[edit]- C02LC01 Clonidine and diuretics
- C02LC05 Moxonidine and diuretics
- C02LC51 Clonidine and diuretics, combinations with other drugs
C02LE Alpha-adrenoreceptor antagonists and diuretics
[edit]- C02LE01 Prazosin and diuretics
C02LF Guanidine derivatives and diuretics
[edit]- C02LF01 Guanethidine and diuretics
C02LG Hydrazinophthalazine derivatives and diuretics
[edit]- C02LG01 Dihydralazine and diuretics
- C02LG02 Hydralazine and diuretics
- C02LG03 Picodralazine and diuretics
- C02LG51 Dihydralazine and diuretics, combinations with other drugs
- C02LG73 Picodralazine and diuretics, combinations with psycholeptics
C02LK Alkaloids, excluding rauwolfia, in combination with diuretics
[edit]- C02LK01 Veratrum and diuretics
C02LL MAO inhibitors and diuretics
[edit]- C02LL01 Pargyline and diuretics
C02LN Serotonin antagonists and diuretics
[edit]C02LX Other antihypertensives and diuretics
[edit]- C02LX01 Pinacidil and diuretics
C02N Combinations of antihypertensives in ATC-group C02
[edit]- Empty group
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code C02". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QC02". WHO Collaborating Centre for Drug Statistics Methodology.